Indegene and Tealium on Pharma’s First-party Data Imperative

With the near-complete deprecation of third-party cookies and intensification of privacy laws (HIPAA, GDPR, CCPA), pharma and biotech companies are prioritizing the collection of secure, compliant, first-party data as a competitive differentiator. Top organizations are now integrating their digital campaigns, CRM, and advanced analytics into unified customer data platforms (CDPs) to orchestrate seamless, consent-driven engagement across every channel.

This also requires that pharma brand teams and pharma marketers adapt their approach to better understand customer data to drive messaging and activation. Marketers must now understand:

With third-party data on the verge of obsolescence, the strategic value of first-party, or self-curated, data is becoming undeniable. Beyond bridging the gaps between fragmented, disconnected data sets, it can serve as the foundation for truly orchestrated omnichannel marketing in pharma. Achieving this, however, demands that pharma marketers invest in a well-designed customer data platform (CDP) and a robust first-party data strategy from the outset.

Significant volumes of behavioural and interaction data flow in from owned brand websites and portals, email campaigns, CRM systems, social media, subscription lists, sales interactions, and customer feedback forms. To harness this potential, life sciences brands need to bring these data streams together in a central CDP to create a single, unified view of the customer.

Once that unified view is in place, organizations can apply AI-powered analytics and predictive modelling to unlock even greater value. Many pharma leaders are moving beyond basic CRM or CMS capabilities, enhancing these platforms with real-time data APIs and advanced intelligence to surface actionable insights from both clinical and commercial datasets. Techniques such as propensity scoring and omnichannel journey mapping help teams anticipate the needs of HCPs and patients before these needs are expressed, enabling precise personalisation while meeting all regulatory requirements.

Modern consent and preference management systems, including specialist platforms such as OneTrust and TrustArc, are now integral to pharma MarTech stacks. These tools keep consent records transparent and up to date, giving organizations detailed control over how, where, and when each data point is used. This strengthens confidence among regulators and stakeholders, ensuring that all engagement is supported by strong, patient-centred data governance.

Many leading pharma companies are also refining their approach to identity matching. Deterministic methods provide complete accuracy when directly engaging verified professionals. Probabilistic methods enrich profiles by interpreting behavioural signals from anonymised traffic, offering an effective alternative when direct identifiers are unavailable. Used together, and supported by CDPs such as Tealium with dedicated pharma modules, these methods deliver both precision and scale in digital outreach.

This precision not only enhances the customer experience but also ensures marketing spend is used effectively. It reduces irrelevant messaging and campaigns that fail to resonate, and focuses resources where they will create measurable impact.

CDPs have several key benefits or pharma, including:

However, to get started quickly, pharma marketers must focus on a few key areas:

Tealium's CDP collects and unifies first- (and third-) party data across channels in real time, helping deliver personalized and specialized care to patients, members, and pharmaceutical providers. The Tealium CDP offers life sciences organizations an enterprise-grade data foundation across all their properties while ensuring customer data are secure and protected in a HIPAA-compliant, private cloud deployment. Digital and offline data are combined seamlessly in a marketer-friendly tool, making first-party data the primary source for 1-to-1 marketing.

Indegene's unique five-stage city planning approach to consulting and implementation ensures that life sciences organizations effectively implement and benefit from their Tealium CDP investment. Starting from a 360-degree analysis of your existing MarTech stack and data model, integrating new and existing tools to your CDP ecosystem, to creating business rules and defining segments, Indegene's expert consultants customize and implement the Tealium CDP to fit your first-party data strategy. Indegene also evaluates and optimizes the implementation with industry-leading tracking and analytics expertise, giving organizations the capabilities needed to deliver the best cross-channel experiences in real time.

The result is a robust first-party data management and insights foundation that will shift your pharma organization from a reliance on third-party data sources and providers.

Collaborating with a specialist pharma consulting and technology company like Indegene brings more than just subject-matter expertise. It ensures every initiative is grounded in a privacy-first, patient-first mindset. This not only addresses today’s compliance demands but also positions pharma organizations to adapt smoothly to regulatory shifts, harness new technologies, and compete confidently in a data-driven market.